NeoVista

company

About

NeoVista develops medical technologies that advance the treatment of wet age-related macular degeneration (AMD).

  • 11 - 50

Details

Last Funding Type
Series B
Last Funding Money Raised
$26M
Industries
Health Care,Health Diagnostics,Medical Device
Founded date
Jan 1, 2002
Number Of Employee
11 - 50
Operating Status
Active

NeoVista Inc is dedicated to the development of medical technologies that help to advance the treatment of wet age-related macular degeneration (AMD). Wet AMD affects more than 5 million people around the world and is a major cause of blindness in men and women over the age of 50.

The unique technology being developed by NeoVista continues to show promise in clinical studies. It is our goal to help improve the quality of care and reduce the burden of this destructive condition on patients, physicians, and the healthcare system.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
6
$126M
NeoVista has raised a total of $126M in funding over 2 rounds. Their latest funding was raised on May 14, 2012 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 14, 2012 Series Unknown $6M 1 Detail
Feb 13, 2011 Series E $33M 1 Detail
Mar 16, 2009 Series D $18M 1 Detail
Dec 7, 2006 Series C $41M 1 Detail
Sep 18, 2006 Series B $26M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
NeoVista is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures Series Unknown